Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCR αβ T Cell Depleted Haploidentical Transplant in AML

Conditions: AML, Childhood; Aml; Acute Myeloid Leukemia, Pediatric; Acute Myeloid Leukemia Interventions: Drug: Rabbit Anti thymocyte globulin; Drug: Busulfan; Drug: Fludarabine; Drug: Thiotepa; Drug: Melphalan; Biological: TCR alpha beta / CD19+ depleted haploidentical hematopoietic progenitor cell graft; Biological: memory-like natural killer cells; Biological: IL-2; Drug: Plerixafor; Biological: Granulocyte Colony-Stimulating Factor; Device: CliniMACS Sponsors: Washington University School of Medicine; The Leukemia and Lymphoma Society; Rising Tide Foundation; St. Louis Children ' s Hospital Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials